@article{b17902c87a6743b48490a1e353ce4c52,
title = "The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation Trust",
author = "C. Crockett and F. Gomes and C. Faivre-Finn and S. Howell and V. Kasipandian and E. Smith and D. Thomson and J. Yorke and J. Price",
note = "Funding Information: In January 2019, The Christie, a large UK tertiary cancer hospital, launched an ePROMs service ({\textquoteleft}MyChristie-MyHealth{\textquoteright}) integrating ePROM questionnaires into care pathways for adult patients with lung and head and neck cancers and patients treated with proton beam therapy. Early financial support was obtained from a pump-priming grant by The University of Manchester and Manchester Cancer Research Centre (MCRC). Subsequently, a business case supported by Christie clinical teams, Trust executives and the MCRC was submitted to The Christie Charity and ongoing funding secured. At the time of writing, ePROMs have been rolled out in further areas, including lymphoma clinics, and for patients treated with immune checkpoint inhibitors, tyrosine kinase inhibitors and anti-HER2 therapies. The ePROM service should be rolled out to all disease groups by the end of 2022 ( Figure 1 ). Funding Information: The Christie ePROMs service is funded by a grant from The Christie Charity, the Manchester Cancer Research Centre and The University of Manchester . C. Faivre-Finn and J. Yorke are supported by a grant from the NIHR Manchester Biomedical Research Centre .",
year = "2021",
month = jul,
doi = "10.1016/j.clon.2021.06.004",
language = "English",
journal = "Clinical Oncology",
issn = "0936-6555",
publisher = "W.B. Saunders Co. Ltd",
}